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TauNeural network breakdown is a key issue in neurodegenerative disease, but the mechanisms are poorly
understood. Here we investigated patterns of brain atrophy produced by deﬁned molecular lesions in the
two common forms of genetically mediated frontotemporal lobar degeneration (FTLD). Nine patients with
progranulin (GRN) mutations and eleven patients with microtubule-associated protein tau (MAPT)
mutations had T1 MR brain imaging. Brain volumetry and grey and white matter voxel-based morphometry
(VBM) were used to assess patterns of cross-sectional atrophy in the two groups. In a subset of patients with
longitudinal MRI rates of whole-brain atrophy were derived using the brain-boundary-shift integral and a
VBM-like analysis of voxel-wise longitudinal volume change was performed. The GRN mutation group
showed asymmetrical atrophy whereas the MAPT group showed symmetrical atrophy. Brain volumes were
smaller in the GRN group with a faster rate of whole-brain atrophy. VBM delineated a common anterior
cingulate–prefrontal–insular pattern of atrophy in both disease groups. Additional disease-speciﬁc proﬁles of
grey and white matter loss were identiﬁed on both cross-sectional and longitudinal imaging: GRN mutations
were associated with asymmetrical inferior frontal, temporal and inferior parietal lobe grey matter atrophy
and involvement of long intrahemispheric association white matter tracts, whereas MAPT mutations were
associated with symmetrical anteromedial temporal lobe and orbitofrontal grey matter atrophy and fornix
involvement. The ﬁndings suggest that the effects of GRN and MAPT mutations are expressed in partly
overlapping but distinct anatomical networks that link speciﬁc molecular dysfunction with clinical
phenotype.nancial conﬂicts of interest to
Institute of Neurology, Queen
.
en).
license. © 2009 Elsevier Inc. Open access under CC BY license. Introduction
The role of neural networks in neurodegenerative disease has
attracted much recent interest (Seeley et al. 2006; Seeley et al., 2007;
Seeley, 2008; Seeley et al., 2008; Borroni et al., 2008; Seeley et al.,
2009) however the mechanisms of neural network breakdown
remain poorly understood. Frontotemporal lobar degeneration
(FTLD) presents a useful disease model in which to investigate this
issue. FTLD is the second most common degenerative cause of young-
onset dementia (Pickering-Brown, 2007) and constitutes a clinically,
pathologically and genetically diverse group of diseases which
produce anatomically restricted patterns of frontal and/or temporal
lobe atrophy. Furthermore, in around a third of patients there is an
autosomal dominant family history, offering the prospect of chartinganatomical changes attributable to a deﬁned molecular change (a
disease-causing mutation) in the living brain. In recent years
mutations in two genes, microtubule-associated protein tau (MAPT)
and progranulin (GRN) have been shown to account for many familial
cases of FTLD (Pickering-Brown, 2007; van Swieten et al., 2008).
While the clinical spectrum of both MAPT and GRN mutations is
heterogeneous, certain features occur more frequently in association
with a particular molecular substrate. Patients with MAPT mutations
commonly present with behavioural variant frontotemporal dementia
(bvFTD) which may be accompanied by a corticobasal syndrome
(CBS) or more rarely a progressive supranuclear palsy (PSP)
syndrome (van Swieten & Spillantini, 2007). Cognitively, executive
dysfunction is widely recognized but patients commonly develop
semantic impairment later in the disease (Pickering-Brown et al.,
2008) as well as prominent episodic memory difﬁculties (van Swieten
et al., 2007). Patients with GRN mutations also present most
commonly with bvFTD and there may be an associated CBS (van
Swieten et al., 2008). However, unlike MAPT mutations patients in
this group frequently present with primary progressive aphasia (PPA)
and GRN mutations are more likely to cause early parietal lobe
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Beck et al., 2008). Group and single case studies suggest that atrophy
in association with GRN mutations is asymmetrical and widespread
within the affected hemisphere, involving the frontal, temporal and
parietal lobes even in the presymptomatic phase, whilst atrophy in
association with MAPT mutations is more symmetrical and relatively
restricted within the frontal and temporal lobes (Whitwell et al.,
2007; Beck et al., 2008; Rohrer et al., 2008; Whitwell et al., 2009a).
Despite the considerable neurobiological as well as clinical interest
in delineating signatures of structural damage associated with FTLD,
both to further understanding of regional vulnerability in this group of
disorders and to test the hypothesis that the phenomenology of FTLD
syndromes reﬂects speciﬁc neural network dysfunction (Seeley et al.,
2008; Seeley 2008; Seeley et al., 2009), there are few comparative
cross-sectional imaging studies of genetic FTLD (Ghetti et al., 2008;
Whitwell et al., 2009a) and little is known about the longitudinal
changes in patterns of atrophy. Here we investigated the cross-
sectional and longitudinal imaging features of GRN- and MAPT-
associated FTLD using complementary structural imaging techniques.
A particular aim of the study was to capture mutation-associated
changes both in cortical regions and in underlying white matter tracts
that link cortical regions within distributed neural networks.
Materials and methods
Subjects
The research database of patients with FTLD attending the
Specialist Cognitive Disorders Clinic of the National Hospital of
Neurology and Neurosurgery, London, UK, between 1992 and 2008
was retrospectively reviewed and all patients with MAPT or GRN
mutations were identiﬁed. Eleven patients with a MAPT mutation
(mean (standard deviation) age at baseline scan 53.5 (5.2)) and nine
patients with a GRN mutation (mean (standard deviation) age at
baseline scan 62.9 (6.1)) were included in the study: the MAPT
mutation group comprised 8 patients with a 10 + 16 mutation and
single patients with 10 + 14, S320F and G389R mutations; the GRN
mutation group (described in Beck et al. (2008)) comprised four
patients with a C31fs mutation, two patients with a Q130fs mutation
and single patients with A199V, S203fs and E498fs mutations.
Demographic and baseline neuropsychological data are shown inTable 1
Demographic, genetic and neuropsychological data for the patient groups.
Patient Presenting
syndrome
Mutation Gender Age
at scan
Symptom duration
at scan
VIQ
MAPT1 bvFTD 10+16 M 54.5 7.5 91
MAPT2 bvFTD 10+16 M 58.0 8.0 97
MAPT3 bvFTD S320F M 58.7 7.7 107
MAPT4 bvFTD G389R M 46.1 3.1 77
MAPT5 bvFTD 10+16 F 48.8 6.8 83
MAPT6 bvFTD 10+16 F 53.2 3.2 90
MAPT7 bvFTD 10+14 M 50.1 9.1 100
MAPT8 bvFTD 10+16 M 52.5 5.5 104
MAPT9 bvFTD 10+16 M 45.9 8.9 99
MAPT10 bvFTD 10+16 M 60.7 2.7 99
MAPT11 bvFTD 10+16 F 56.8 1.8 85
GRN1 bvFTD C31fs M 67.4 1.4 84
GRN2 bvFTD Q130fs F 65.5 3.5 59
GRN3 PPA C31fs F 68.3 2.3 85
GRN4 bvFTD Q130fs M 65.9 3.9 107
GRN5 PPA C31fs F 63.0 5.0 84
GRN6 PPA S203fs M 50.6 2.6 66
GRN7 bvFTD C31fs M 56.4 3.4 88
GRN8 PPA/CBS E498fs F 68.4 6.4 Una
GRN9 CBS A199V M 60.7 5.7 61
Verbal IQ (VIQ) and Performance (PIQ) scores are taken from the WAIS-R. Recognition Mem
Space Perception (VOSP) battery results are quoted in percentile scores where a score belo
Wisconsin Modiﬁed Card Sorting Tasks or the Stroop task and are quoted as pass or fail.Table 1. There was no signiﬁcant difference in mean symptom
duration between the two groups, however themean age of theMAPT
groupwas signiﬁcantly younger than the GRN group at the time of the
baseline scan. All patients with MAPT mutations presented initially
with a bvFTD syndrome whilst patients with GRN mutations
presented with bvFTD, PPA or CBS. A control group of ﬁfteen
cognitively-normal controls (10 males, 5 females) were used for
comparison (mean (standard deviation) age at baseline scan 57.5
(5.3)). All patients included in the study had at least one volumetric
brain MRI scan; six patients with a MAPT mutation and four patients
with a GRN mutation had two scans with no signiﬁcant differences in
the mean inter-scan interval between the two groups (GRN — 1.3
(0.2) years; MAPT — 2.1 (1.0) years).
Brain imaging
All patients had MR imaging on a 1.5 T GE Signa scanner (General
Electric, Milwaukee, WI). T1-weighted volumetric brain images were
obtained using an IR-prepared fast SPGR sequence (TE=5 ms,
TR=12 ms, and TI=650 ms) with a 24-cm ﬁeld of view and
256×256matrix to provide 124 contiguous 1.5-mm-thick slices in the
coronal plane. We initially calculated whole-brain and hemisphere
volumes in all patients. The brain region was created by segmenting
the whole brain using a semi-automated technique in the MIDAS
software package (Freeborough et al., 1997a). For rates of atrophy in
patients with longitudinal imaging, serial scans were co-registered
and volume change was calculated directly using the boundary shift
integral (BSI) (Freeborough et al., 1997b). BSI-derived whole-brain
volume changes (BBSI) were expressed as annualized percentage
change from the baseline brain volume. Analysis of hemispheric
volume was also performed: scans and associated whole-brain
regions were initially transformed into standard space by registration
to the Montreal Neurological Institute (MNI) Template. The left and
right hemispheric regions were deﬁned using the MNI average brain
which was split by dividing the whole volume along a line coincident
with the interhemispheric ﬁssure. An intersection of each individual's
brain region and the hemispheric regions deﬁned on the MNI
template was generated to provide a measure of brain volume in
left and right hemispheres. A left/right asymmetry ratio measure was
calculated by dividing the left hemisphere volume by the right
hemisphere volume. Cross-sectional and longitudinal volumetric dataPIQ RMT words RMT faces GNT VOSP Executive
dysfunction
96 b5th b5th b5th b5th Pass
107 b5th b5th b5th N50th Pass
128 N75th 5–10th b5th 25–50th Pass
70 b5th b5th b5th N10th Fail
81 10–25th b5th b5th 50–75th Pass
84 10–25th b5th b5th 25–50th Fail
96 b5th b5th b5th NT NT
121 5–10th 5–10th b5th N75th Pass
93 b5th b5th 5–10th N5th Pass
105 b5th b5th b5th N10th Pass
97 b5th 25–50th 50–75th N5th Pass
72 b5th b5th 10–25th b5th Fail
74 b5th b5th b5th b5th Fail
108 50–75th 10–25th b5th 25–50th Pass
95 25th 10–25th N75th N5th Fail
86 10–25th b5th 25–50th 25–50th Fail
98 25–50th N75th b5th N50th Pass
80 25–50th 25–50th 50–75th N50th Fail
ble 69 5–10th b5th b5th b5th NT
Unable Unable Unable b5th b5th Fail
ory Test (RMT) for Words and Faces, Graded Naming Test (GNT) and Visual Object and
w the 5th percentile is considered impaired. Executive function tasks are the Weigl or
Table 2
Volumetric cross-sectional and longitudinal data.
Mean (95% conﬁdence intervals) MAPT mutations GRN mutations Controls
Whole-brain volume (ml) 1117.3 (1079.6, 1162.5)a 996.8 (914.0, 1099.2)a,b 1230.5 (1180.2, 1272.6)
Whole-brain BSI atrophy rate (%/yr) 1.4 (0.9, 1.9)a 3.4 (2.8, 4.0)a,b 0.3 (0.1, 0.4)
Left hemisphere volume (ml) 553.5 (536.4, 573.4)a 496.4 (460.8, 545.4)a,b 605.2 (581.3, 626.3)
Right hemisphere volume (ml) 552.0 (531.8, 574.9)a 489.8 (437.0, 562.1)a 605.9 (581.6, 625.3)
Left/right hemisphere ratio 1.00 (0.99, 1.02) 1.03 (0.93, 1.15) 1.00 (0.99, 1.01)
a pb0.05 disease group signiﬁcantly worse than Controls.
b pb0.05 GRN mutation group signiﬁcantly worse than MAPT mutation group.
Fig. 1. Annualized rates of whole-brain atrophy (as measured using the boundary shift
integral) in the MAPT mutation (diamonds) and GRN mutation (triangles) groups as
well as the controls (circles).
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College Station, TX) by examining contrasts between the groupmeans
using a linear regression model. 95% bias-corrected bootstrap
conﬁdence intervals with 1000 replicates were used.
Voxel-based morphometry (VBM) was performed on the baseline
images using SPM5 software (http://www.ﬁl.ion.ucl.ac.uk/spm)with
default settings for all parameters. The images underwent an initial
segmentation process in SPM5 which simultaneously estimated
transformation parameters for warping grey matter (GM), white
matter (WM) and cerebrospinal ﬂuid (CSF) tissue probability maps
(TPMs) onto the images. The native space GM and WM segments
were then rigidly spatially normalised, using just the rotations and
translations from the inverse of the TPM transformation, and
resampled to 1.5 mm isotropic resolution. These “imported” images
were then iteratively warped to an evolving estimate of their group-
wise GM and WM average template using the DARTEL toolbox
(Ashburner, 2007; Ashburner et al., 2009). The GM and WM
segmentations were then normalised using the ﬁnal DARTEL
transformations and modulated to account for volume changes.
Finally, the images were smoothed using a 6 mm full-width at half-
maximum (FWHM) Gaussian kernel. Linear regression models were
used to examine differences in GM and WM volume between the
groups. Voxel intensity, V, was modelled as a function of group, and
subject age and total intracranial volume (TIV) were included as
nuisance covariates. Separate analyses were performed on the grey
matter and white matter segments. Maps showing statistically
signiﬁcant differences between the groups were generated, correcting
formultiple comparisons in the disease group-control comparisons by
thresholding the images of t-statistics to control the False Discovery
Rate (FDR) at a 0.001 signiﬁcance level. For disease group compar-
isons maps were generated uncorrected at a 0.001 signiﬁcance level.
Statistical parametric maps were displayed as overlays on a study-
speciﬁc template, created by warping all native space whole-brain
images to the ﬁnal DARTEL template and calculating the average of
the warped brain images. In order to visualise hemispheric asymme-
tries, we performed two VBM analyses: ﬁrstly with all images in their
native space; and secondly, with native images ﬂipped in the
midsagittal plane within SPM5, such that the most severely affected
cerebral hemisphere was on the same side in each patient. An image
was selected for ﬂipping if it had a hemispheric asymmetry index
outside the control range and more severe right hemisphere atrophy
(i.e., images were ﬂipped such that any asymmetric atrophy was
displayed on the left): four images from the GRN group and three
from the MAPT group met criteria for ﬂipping.
For those patients with longitudinal imaging (6 MAPT patients and
4 GRN patients) we performed non-linear registration of each follow-
up image to its corresponding baseline using a multi-scale viscous
ﬂuid algorithm (Crum et al., 2003) with a Normalised Mutual
Information objective function (Crum et al., 2005). Image pairs were
ﬁrst ﬂipped such that the most severely affected cerebral hemisphere
was on the same side in each patient as with the VBM analysis. We
computed maps of the ﬂuid registration Jacobian determinants,
encoding the relative volume change from baseline to follow-up,
which can be analysed using SPM, following Scahill et al. (2002).These ‘Voxel Compression Maps’ (VCMs) were log-transformed as in
Scahill et al., but instead of separating out expansion and contraction
before smoothing, we separated each subject's VCM into GM,WM and
CSF components according to which tissue segment had the highest
probability at each voxel. The sets of tissue-speciﬁc VCMs were then
spatially normalised using the DARTEL transformations and smoothed
using a 6 mm FWHM Gaussian kernel as used for the VBM analysis.
The GM and WM analysis masks from the cross-sectional analysis
were reused, as was the average template for overlaying results.
Voxel-wise statistical analysis was then performed using SPM5, with a
linear regression model comprising group indicator variables and
nuisance covariates of age, TIV, and inter-scan interval.
Results and discussion
Results
Volumetric data
Whole-brain volumes and rate of atrophy. Baseline brain volumes
were smaller in both disease groups compared to healthy controls and
mean brain volume was signiﬁcantly smaller in the GRN group
compared to the MAPT group (Table 2). Rates of whole-brain atrophy
were signiﬁcantly greater in the GRN group with no overlap with the
MAPT group (Table 2, Fig. 1).
Hemisphere volumes. Baseline mean left and right hemisphere
volumes were smaller in the disease groups than the controls and
mean left hemisphere volume was signiﬁcantly smaller in the GRN
group compared to theMAPT group,with a trend to smallermean right
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The overall mean left/right asymmetry ratio was similar in all three
groups, however individual cases in the GRN group were highly
asymmetrical with all cases falling outside of the control range
(Fig. 2A), whereas individual cases in the MAPT group were most
often symmetrical with a few cases just falling outside the control
range. Only a single GRN patient (GRN5) fell within the range of
values of the MAPT group. Furthermore, in the patients with
longitudinal imaging, GRN cases became more asymmetric as the
disease progressed whilst MAPT patients remained similarly
symmetrical (Fig. 2B).
VBM data
Grey matter atrophy in disease groups versus controls. Patterns of
grey matter atrophy differed in the MAPT and GRN groups compared
to healthy controls. The GRN group analysis on unﬂipped images
showed an overall pattern of symmetrical brain atrophy including
frontal, temporal and parietal lobes, cingulate cortex and thalamus.
However, this result obscures any asymmetries in favour of left or
right hemisphere at individual subject level: after ﬂipping of images
so that all patients had the most affected hemisphere in the same
orientation the true asymmetry of GRN disease was apparent
(Fig. 3). The most signiﬁcant areas of grey matter atrophy were in
the inferior frontal lobe, dorsal insula, superior and middle temporal
gyri, dorsal anterior cingulate cortex, precuneus and inferior parietal
lobe. In contrast, the MAPT group analysis on ﬂipped images
revealed a distinct symmetrical pattern of atrophy including anterior
and medial temporal lobes, orbitofrontal cortex and ventral insula
with less involvement of the anterior cingulate (Fig. 3).Fig. 2. Left/right hemisphere volume ratio in the three groups (A) and in patients with lonWhite matter atrophy in disease groups versus controls. In the GRN
group compared to controls, the white matter VBM analysis showed
most signiﬁcant involvement of intrahemispheric long association
tracts including inferior longitudinal fasciculus, superior longitudinal
fasciculus, inferior fronto-occipital fasciculus and cingulum. There
was additional involvement of the corpus callosum and brainstem
tracts, particularly in the pons (Fig. 3). In theMAPT group compared to
controls, the most signiﬁcant areas of white matter loss lay in the
fornices bilaterally with less marked involvement of the uncinate
fasciculus (Fig. 3).
GRN versus MAPT group comparisons. Comparing the two mutation
groups directly in the ﬂipped VBM analysis (Fig. 4) revealedmutation-
associated atrophy proﬁles involving brain regions previously
identiﬁed in the control comparison. The GRN group had more
marked and asymmetric grey matter loss in inferior frontal lobe,
dorsal insula, posterior temporal and inferior parietal lobes and
precuneus, and more marked and similarly asymmetric white matter
loss in superior longitudinal fasciculus and cingulum. TheMAPT group
had more marked grey matter loss in the anterior and medial
temporal lobes bilaterally and more prominent involvement of the
fornices (Fig. 4).
Longitudinal non-linear registration data
Differential patterns of longitudinal volume loss in the two
mutation groups were similar to those seen in the cross-sectional
VBM analysis (Fig. 5). The GRN group showed longitudinal volume
loss asymmetrically involving mainly the inferior frontal, superior
temporal, and inferior parietal lobes, precuneus and cingulate cortex
as well as the long association white matter tracts. The MAPT groupgitudinal imaging as a function of disease duration i.e. time from symptom onset (B).
Fig. 3. VBM analysis on grey matter (GM) and white matter (WM) regions in GRN- and MAPT-associated FTLD relative to healthy controls. Statistical parametric maps (SPMs) have
been thresholded at pb0.001 after false discovery rate correction over the whole-brain volume and rendered on a study-speciﬁc average group T1-weighted MRI template image in
DARTEL space. The colour bar (lower right) indicates the t score. Left (L) and right (R) markers are shown for ease of reference however this analysis was performed on ﬂipped
images (see text). GM panels show the same series of coronal MR sections in the GRN and MAPT cases; WM panels show coronal (above) and sagittal (below) sections based on
zones of maximal white matter loss in each disease group.
1074 J.D. Rohrer et al. / NeuroImage 53 (2010) 1070–1076showed longitudinal volume loss symmetrically involving the ante-
romedial temporal lobes, orbitofrontal cortex and white matter tracts
including the corpus callosum.
Discussion
Using convergent imaging techniques, we have shown that GRN
and MAPT mutations are associated with distinct proﬁles of neuronal
loss affecting distributed cortical areas and their white matter
connections. GRN mutations are associated with asymmetric atrophy
of frontal, insular, cingulate, parietal and temporal areas linked by
intrahemispheric long association tracts, while MAPT mutations are
associated with more restricted but bi-hemispheric atrophy of
anteromedial temporal and orbitofrontal areas linked via the fornices
and uncinate fasciculi. Disease evolution is more rapid in GRN- than
MAPT-associated FTLD, as predicted from the more distributed
cerebral damage associated with GRN mutations. Moreover, the
degree of asymmetry increases over time in the GRN- (but not the
MAPT) associated cases: in conjunction with the evidence presented
here for asymmetric longitudinal intrahemispheric volume loss, this
increasing asymmetry implies that the pathological process in GRN-
associated FTLD is focused within the maximally affected hemisphere.
The proﬁles of grey matter involvement demonstrated here help to
integrate previous evidence concerning anatomical signatures and
disease evolution in GRN and MAPT mutation cases. In particular, our
ﬁndings suggest an anatomical substrate for the shorter disease
duration (Beck et al., 2008) and greater asymmetry of disease
involvement (Beck et al., 2008; Ghetti et al., 2008; Rohrer et al.,2008) observed with GRN compared with MAPT mutations while
underlining the individual variability in lateralisation that may make
asymmetry more difﬁcult to detect in group morphometric studies
(Whitwell et al., 2009a).
White matter involvement in FTLD has been little studied but long
association tracts including the anterior cingulum and superior
longitudinal fasciculus have been implicated (Seeley et al., 2008;
Borroni et al., 2008). A diffusion tensor imaging study in presymp-
tomatic patients with GRNmutations showed left uncinate fasciculus,
arcuate fasciculus (part of the superior longitudinal fasciculus), and
left inferior fronto-occipital fasciculus (Borroni et al., 2008). In the
present study, the use of an unbiased technique (VBM) has revealed
distinct patterns of white matter tract involvement associated with
GRN and MAPT mutations, including pathways (such as the fornix)
not previously identiﬁed in imaging studies of genetic FTLD. It will be
important in future studies of genetic FTLD to investigate the
complementary information about white matter tracts that can be
provided by diffusion tractography (Mori & Zhang, 2006).
Neural network dysfunction has been proposed to underpin
phenotypic features of neurodegenerative disease including FTLD
(Seeley et al., 2009), and in particular, behavioural dysfunction in
bvFTD has been ascribed to selective vulnerability of von Economo
neuronswithin a frontal–insula–anterior cingulate network (Seeley et
al., 2006; Seeley et al., 2007; Seeley 2008; Seeley et al., 2008). The
present ﬁndings indicate that this network is affected by both GRN
and MAPT mutations, suggesting that it is vulnerable to different
pathological processes in FTLD. However, the most signiﬁcant areas of
atrophy here were differentiated according to the underlying
Fig. 4. VBM analysis comparing grey matter (GM) and white matter (WM) atrophy between GRN- and MAPT-associated FTLD groups. Left-hand panels show regions where tissue
intensity was reduced in the GRN group relative to theMAPT group (GRNbMAPT) and right-hand panels show regions where tissue intensity was reduced in theMAPT group relative
to the GRN group (MAPTbGRN). Statistical parametric maps (SPMs) have been thresholded at pb0.001 (uncorrected) and rendered on the same template used in Fig. 3. The colour
bar (lower right) indicates the t score. Left (L) and right (R) markers are shown for ease of reference however this analysis was performed on ﬂipped images (see text). Sections
shown are based on zones of maximal grey and white matter loss in each disease group.
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consistent with involvement of a ventral orbitofrontal–medial
temporal–ventral insula network while the atrophy proﬁle of GRN
mutations is consistent with involvement of a more dorsal and
asymmetrical anterior cingulate–dorsal insula–temporal–parietal
network. This suggests that large-scale neural network dysfunction
may be a signature of speciﬁc molecular pathologies within the FTLD
spectrum. The genetically deﬁned networks identiﬁed here areFig. 5. Longitudinal voxel compression map analysis showing comparison between GRN- an
MAPT group, and blue greater in GRN. Top panel shows greymatter (GM)maps and bottom p
used in Fig. 3. Because of the very small groups, we present only unthresholded maps of the g
at an uncorrected 0.001 level. These unthresholded maps of effect–size show the characteraligned with anatomically similar functional networks delineated in
functional connectivity and resting-state network fMRI studies of
healthy individuals (Beckmann et al., 2005; Damoiseaux et al., 2006;
Margulies et al., 2007; Seeley et al., 2009). Network dysfunction here
may provide a neuropathological bridge between molecular dysfunc-
tion and clinical phenotype in different genetically mediated forms of
FTLD: clinically, MAPT mutations produce behavioural symptoms
(especially disinhibition) and later semantic impairment consistentd MAPT-associated FTLD groups. Red indicates more severe longitudinal atrophy in the
anel showswhite matter (WM)maps, which are overlaid on the same average template
roup-difference, rather than thresholded t-maps, which show only a few isolated peaks
, but not the signiﬁcance, of the group differences.
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(Seeley et al., 2009); while GRN mutations may produce bvFTD
(with early involvement of the dorsal network in the right cerebral
hemisphere), progressive aphasia (with early involvement of the
dorsal network in the left cerebral hemisphere) or a corticobasal
syndrome (with early involvement of more posterior parts of the
dorsal network in either hemisphere).
A crucial unsolved question concerns the mechanisms whereby
different molecular lesions may produce strikingly dissimilar patterns
of neural network breakdown. There are three interrelated patho-
physiological issues here: ﬁrstly, how one mutation produces
asymmetrical cerebral damage and another more symmetrical
damage; secondly, how these distinctive patterns of atrophy are
maintained or ampliﬁed as the disease evolves; and ﬁnally, how
phenotypic variation arises such that a particular mutation may
selectively damage different cerebral hemispheres even between
members of the same family (Beck et al., 2008). The variable clinical
presentation of genetic FTLD suggests that molecular lesions do not
specify a precise initial anatomical locus of brain damage: the
initiation of disease in a particular brain region may be a stochastic
event or could reﬂect hemispheric vulnerability due to developmental
or other environmental factors (Mesulam, 2009). However, the
evidence from this study suggests that, once initiated, the pattern of
disease evolution and the type of evolution that can occur are
constrained by the underlying molecular abnormality. Particular
mutations are likely to exert their effects via the patterns of large-
scale network connectivity that exist in the healthy brain, with
connectivity between homotopic cortical areas (which is variable in
different parts of the brain) being a crucial factor in linking a particular
molecular lesion with symmetrical or asymmetrical network involve-
ment (Stark et al., 2008). At a molecular level, GRN and MAPT are
likely to be differently toxic to neurons: loss of GRN-mediated trophic
support (Eriksen & Mackenzie, 2008) might particularly disrupt long
axonal connectionswithin a hemisphere, whereas inMAPT-associated
FTLD, toxic gain of function (Gendron & Petrucelli, 2009) and the
effects of diffusible tauwith local spread to neighbouring brain regions
(Brunden et al., 2008; Clavaguera et al., 2009) might lead to relatively
restricted damage maximally affecting nearby synapses and local
interneuronal populations within a functional brain region.
The concept of large-scale neural network breakdown linked to
speciﬁc molecular lesions may be relevant to the pathogenenesis of a
number of neurodegenerative pathologies. Speciﬁc mutations within
a general category of genetically mediated neurodegeneration (such
as GRN or MAPT-associated FTLD) may mediate more ﬁne-grained
proﬁles of brain damage, as suggested by recent evidence within the
MAPT spectrum (Whitwell et al., 2009b). The small case numbers in
the present study do not allow conclusions to be drawn about such
ﬁne-grained mutation speciﬁcity, underlining a need for larger
mutation cohorts recruited via multiple centres in future studies. A
related priority is the identiﬁcation of earliest network-level
changes in presymptomatic mutation carriers. In particular, further
work is required to test the hypotheses proposed here and to establish
the true status of molecular network dysfunction in the pathogenesis
of FTLD and indeed, the broader spectrum of neurodegenerative
disease.
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